Diabetes
Novo Nordisk once-weekly insulin clears first phase 3 test
Phil Taylor
Diabetes, drug delivery, insulin, insulin icodec, metabolic disease, Novo Nordisk
0 Comment
Abbott joins alliance to bring ‘artificial pancreas’ system to Europe
Phil Taylor
Abbott, artificial pancreas, CamDiab, Diabetes, digital, digital health, Ypsomed
0 Comment
Market Access/ Views and analysis
Why the drug pricing debate is focused on insulin
Ben Hargreaves
Diabetes, Drug pricing, insulin, pharma, PhRMA
0 Comment
NICE expands access to real-time glucose monitoring for diabetics
Phil Taylor
continuous glucose monitoring, Diabetes, NHS, NICE
0 Comment
News/ News/ Sales and Marketing
Insulin price caps on the horizon as Senate leader plans vote
Phil Taylor
Diabetes, Drug pricing, insulin, legislation, US
0 Comment
Does COVID-19 infection raise the risk of diabetes?
Phil Taylor
coronavirus, COVID-19, Diabetes, patients
0 Comment
Real-time Abbott glucose monitor available to NHS after UK launch
Phil Taylor
Abbott, continuous glucose monitoring, Diabetes, digital, digital health, FreeStyle Libre, NHS, wearable
0 Comment
EU clears Bayer’s chronic kidney disease drug Kerendia
Phil Taylor
Bayer, chronic kidney disease, Diabetes, EU, finerenone, Kerendia, regulatory approval
0 Comment